BIOMAT Database Logo BIOMAT Database Logo

Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients. 1999

S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
Department of Toxicology, National Institute of Occupational Health, Oslo, Norway. Steen.Mollerup@stami.no

Several epidemiological studies have indicated that female tobacco smokers may be at higher risk of lung cancer than males. In a study of lung cancer cases, we have found that female smokers had a significantly higher level of aromatic/hydrophobic DNA adducts in their nontumor lung tissue (15.39+/-9.47 adducts/10(8) nucleotides, n = 29) than male smokers (12.08+/-8.14, a = 93; P = 0.047). Females had significantly higher levels of adducts/pack-year (females 0.95+/-0.82 adducts/pack-year and males 0.46+/-0.46; P = 0.0004) and adducts/cigaret/day (females 1.48+/-1.29 and males 0.89+/-0.74, P = 0.015). By quantitative reverse transcription-PCR, it was found that female smokers exhibited a significantly higher expression level of lung CYP1A1 (494+/-334 CYP1A1 mRNA/10(6) glyceraldehyde-3-phophate dehydrogenase mRNA, n = 15) compared with males (210+/-208, n = 12; P = 0.016). Furthermore, for both sexes combined a significant correlation between CYP1A1 expression and DNA adduct level was found (r = 0.50, P = 0.009). In conclusion, the observed sex difference in aromatic/hydrophobic DNA adduct levels may at least in part be explained by different levels of CYP1A1 expression.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009603 Nitroso Compounds Organic compounds containing the nitroso (-N Compounds, Nitroso
D011084 Polycyclic Aromatic Hydrocarbons Aromatic hydrocarbons that contain extended fused-ring structures. Polycyclic Aromatic Hydrocarbon,Polycyclic Hydrocarbons, Aromatic,Polynuclear Aromatic Hydrocarbon,Polynuclear Aromatic Hydrocarbons,Aromatic Hydrocarbon, Polycyclic,Aromatic Hydrocarbon, Polynuclear,Aromatic Hydrocarbons, Polycyclic,Aromatic Hydrocarbons, Polynuclear,Aromatic Polycyclic Hydrocarbons,Hydrocarbon, Polycyclic Aromatic,Hydrocarbon, Polynuclear Aromatic,Hydrocarbons, Aromatic Polycyclic,Hydrocarbons, Polycyclic Aromatic,Hydrocarbons, Polynuclear Aromatic
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D005260 Female Females

Related Publications

S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
Gender difference in DNA adduct levels among nonsmoking lung cancer patients.
January 2001, Environmental and molecular mutagenesis,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
August 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP),
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
An association between BPDE-like DNA adduct levels and CYP1A1 and GSTM1 polymorphisma in pterygium.
April 2010, Molecular vision,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
Sex differences in psychologic symptoms among patients with newly diagnosed lung cancer.
June 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
The measurement of cisplatin-DNA adduct levels in testicular cancer patients.
October 1988, Carcinogenesis,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
Polycyclic aromatic hydrocarbon--DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung.
June 1992, Carcinogenesis,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
Sex Differences in Lung Cancer.
June 2023, Cancers,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels.
October 1996, Carcinogenesis,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
Aromatic DNA adduct levels in coke oven workers: correlation with polymorphisms in genes GSTP1, GSTM1, GSTT1 and CYP1A1.
May 2002, Mutation research,
S Mollerup, and D Ryberg, and A Hewer, and D H Phillips, and A Haugen
LacI transgenic animal study: relationships among DNA-adduct levels, mutant frequencies and cancer incidences.
June 2001, Mutation research,
Copied contents to your clipboard!